BVMF
GRND3
Market cap816mUSD
Oct 08, Last price
4.54BRL
1D
4.61%
1Q
16.71%
Jan 2017
-17.00%
IPO
119.32%
Name
Grendene SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Sobral, Brazil, in 1971, Grendene S.A. is a prominent footwear enterprise. The company is actively involved in the creation, production, and worldwide distribution of shoes designed for women, men, and children, concentrating heavily on the Brazilian market. Its diverse brand lineup includes popular names such as Melissa, Rider, Grendha, Ipanema, Ilhabela, Zaxy, Cartago, Pega Forte, Grendene Kids, and Zizou. Grendene also holds licenses for the use of celebrity and children's character brands to augment its range for younger audiences. The company maintains a substantial retail footprint, featuring a Melissa showroom in Milan, approximately 336 franchised Clube Melissa outlets across Brazil, and four distinct concept stores: Galeria Melissa branches in São Paulo, New York, and London, plus a Casa Ipanema store in Rio de Janeiro. Its products are sold through commercial representatives, an extensive network of distributors, and direct export operations.
Key people
Chairman of the Board · since 2013
Rudimar Dall'Onder
Chief Executive Officer, Member of the Executive Board · since 2022
Gelson Luis Rostirolla
Deputy Chief Executive Officer, Member of the Executive Board · since 2022
Vice Chairman of the Board · since 2013
Alceu De Albuquerque
Chief Financial and Administrative Officer, Investor Relations Officer, Member of the Executive Board · since 2024
Member of the Board of Directors
Member of the Board of Directors
Renato Ochman
Member of the Board of Directors
Walter Janssen Neto
Independent Member of the Board of Directors
Bruno Rocha
Independent Member of the Board of Directors
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||